,4 Mevalonate pathway dysregulation contributes to tumor growth, metastasis, and therapy resistance in various cancers, including PDAC.3, 4, 5 The pathway is tightly linked to Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven oncogenic signaling, revealing its fundamental importance in PDAC biology. This evidence concerns the gene KRAS and neoplasm.